BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1282288)

  • 21. An unexpected increase in circulating IFN-gamma by cyclosporin A in atopic patients: a discrepancy between in vitro and in vivo events.
    Shiohara T; Sagawa Y; Nagashima M
    Acta Derm Venereol; 1994 Jan; 74(1):20-1. PubMed ID: 7908481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FcIgG receptor-bearing lymphocytes and monoclonal antibody-defined T cell subsets in atopic dermatitis: effect of treatment with thymopoietin pentapeptide (TP-5).
    Strannegård O; Strannegård IL; Kang K; Cooper KD; Hanifin JM
    Int Arch Allergy Appl Immunol; 1982; 69(3):238-44. PubMed ID: 6752042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A.
    Reinhard T; Möller M; Sundmacher R
    Cornea; 1999 Nov; 18(6):645-51. PubMed ID: 10571292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporin maintenance therapy for severe atopic dermatitis.
    Korstanje MJ; van de Staak WJ
    Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin treatment of atopic dermatitis: five case studies and literature review.
    Stephens RB; Lee ML; Cooper A
    Australas J Dermatol; 1994; 35(2):55-9. PubMed ID: 7702488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin A treatment of severe atopic dermatitis in a child.
    Guarneri B; Califano L; Cannavò SP; Vaccaro M
    Pediatr Dermatol; 1994 Jun; 11(2):186. PubMed ID: 8041666
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of PUVA or UVB treatment on the PHA responsiveness of peripheral lymphocytes in vivo.
    Karvonen J; Ilonen J
    Arch Dermatol Res; 1983; 275(4):261-2. PubMed ID: 6625656
    [No Abstract]   [Full Text] [Related]  

  • 28. Permanent remission of severe atopic dermatitis in a Chinese patient after cyclosporin A therapy.
    Wong SS
    Acta Derm Venereol; 1995 Mar; 75(2):168. PubMed ID: 7604659
    [No Abstract]   [Full Text] [Related]  

  • 29. The Role of Interleukins 4 and/or 13 in the Pathophysiology and Treatment of Atopic Dermatitis.
    Silverberg JI; Kantor R
    Dermatol Clin; 2017 Jul; 35(3):327-334. PubMed ID: 28577802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases.
    Leonardi S; Marchese G; Rotolo N; Miraglia Del Giudice M; La Rosa M
    Minerva Pediatr; 2004 Apr; 56(2):231-7. PubMed ID: 15249910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis.
    Kang K; Cooper KD; Hanifin JM
    J Am Acad Dermatol; 1983 Mar; 8(3):372-7. PubMed ID: 6339571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin in atopic dermatitis: review of the literature and outline of a Belgian consensus.
    Naeyaert JM; Lachapelle JM; Degreef H; de la Brassinne M; Heenen M; Lambert J
    Dermatology; 1999; 198(2):145-52. PubMed ID: 10325461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine A in atopic dermatitis.
    Gaig P; Alijotas J; López A; Valencia M; Cisteró A
    Allergol Immunopathol (Madr); 1993; 21(5):169-72. PubMed ID: 8160560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
    Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
    Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclosporin in atopic dermatitis].
    Pacor ML; Biasi D; Di Lorenzo G; Carletto A; Corrocher R
    Recenti Prog Med; 2001 Jun; 92(6):390-1. PubMed ID: 11433717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic therapy of childhood atopic dermatitis.
    Slater NA; Morrell DS
    Clin Dermatol; 2015; 33(3):289-99. PubMed ID: 25889129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclosporin A in atopic dermatitis: therapeutic effect and effect on allergic reactions are dissociated from each other].
    Munro CS; Higgins EM; Marks JM; Daly BM; Friedmann PS; Shuster S
    Wien Med Wochenschr; 1991; 141(18-19):419-23. PubMed ID: 1776256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on systemic therapies for atopic dermatitis.
    Denby KS; Beck LA
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atopic dermatitis: the role of recombinant interferon-gamma therapy.
    Chang TT; Stevens SR
    Am J Clin Dermatol; 2002; 3(3):175-83. PubMed ID: 11978138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection.
    Gnarra M; De Simone C; Garcovich M; Garcovich S
    Pediatr Dermatol; 2017 May; 34(3):374-376. PubMed ID: 28382768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.